Skip to main content

Day: June 8, 2020

ERES REIT Announces Timing of Second Quarter 2020 Results & Conference Call

TORONTO, June 08, 2020 (GLOBE NEWSWIRE) — European Residential Real Estate Investment Trust (“ERES REIT”) (TSXV:ERE.UN) announced today it will issue its financial results for the three and six months ended June 30, 2020 after markets close on:Monday, August 10, 2020A conference call hosted by Phillip Burns, Chief Executive Officer and the ERES REIT management team to discuss the results will be held on:Tuesday, August 11, 2020 at 9:00 am ETThe telephone numbers for the conference call are:Local / International: (416) 340-2216North American Toll Free: (800) 377-0758 A slide presentation to accompany management’s comments during the conference call will be available an hour and a half prior to the conference call. To view the slides, access the ERES REIT website at www.eresreit.com click on “Investor Info” and follow the...

Continue reading

Summit State Bank Appoints Sharon Wright, Governmental Relations and Public Affairs Consultant, to Board of Directors

SANTA ROSA, Calif., June 08, 2020 (GLOBE NEWSWIRE) — Summit State Bank (NASDAQ: SSBI) appointed Sharon Wright to its Board of Directors.  “We are pleased to welcome Ms. Wright as a Director. Sharon’s extensive experience and dedication to local businesses and nonprofits makes her an excellent addition to our Board of Directors. Sharon served on the Santa Rosa City Council for 12 years and served three terms as Mayor. In addition to her council duties, she served 10 years representing the 9 cities and County of Sonoma on the Metropolitan Transportation Commission.  Her other public sector appointments include the Sonoma County Transportation Authority, Sonoma County Planning Commission and the California Coastal Commission.  As a community bank, we feel strongly about giving back to the community and her commitment to community,...

Continue reading

Autolus Therapeutics reschedules its investor EHA conference call

LONDON, June 08, 2020 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it has rescheduled its investor conference call to discuss data presented at the European Hematology Association EHA25 Virtual Congress to 12 June 2020 at 7:30 am EDT, 12:30 pm BST.  This call was previously announced and scheduled for 15 June 2020.On the call Dr. Christian Itin, chairman and chief executive officer, along with the AUTO1 and AUTO3 clinical teams, will discuss presentations related to the company’s AUTO1 and AUTO3 programs, CAR T cell therapies being investigated in Phase 1/2 studies of adult Acute Lymphocytic Leukemia (ALL) and relapsed/refractory Diffuse Large B Cell Lymphoma (DLBCL), respectively.Investor call on...

Continue reading

CareDx Announces 2020 Annual Meeting of Stockholders to be Held as a Virtual Meeting

SOUTH SAN FRANCISCO, Calif., June 08, 2020 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced a change to its 2020 Annual Meeting of Stockholders.  Due to conditions associated with the impact of the Coronavirus pandemic (COVID-19), including restrictions on in-person gatherings, and in order to support the health and well-being of our stockholders and other meeting participants, CareDx’s 2020 Annual Meeting of Stockholders will be held in a virtual meeting format only.The previously announced date and time of the Annual Meeting, June 17, 2020 at 10:00 a.m. Pacific Time, will not change.  There is also no change to the items...

Continue reading

FibroGen Announces New Roxadustat Data Presented at 2020 ERA-EDTA Virtual Congress

Roxadustat demonstrates non-inferiority to darbepoetin alfa in achievement of Hb correction in DOLOMITES Phase 3 study of anemia in non-dialysis dependent patients with chronic kidney diseaseSAN FRANCISCO, June 08, 2020 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ:FGEN) announced data from three roxadustat clinical trials, including the Phase 3 DOLOMITES study evaluating roxadustat for treatment of anemia in non-dialysis-dependent CKD patients compared to darbepoetin alfa, and ophthalmology findings from a Japan Phase 3 study evaluating roxadustat compared to darbepoetin alfa in patients on hemodialysis 1. These data were presented in virtual oral sessions of the 57th European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Virtual Congress, taking place June 6 – 9, 2020. These trials were conducted...

Continue reading

Quorum Announces an Addition to its Board of Directors

CALGARY, Alberta, June 08, 2020 (GLOBE NEWSWIRE) — Quorum Information Technologies Inc. (TSX Venture: QIS) (“Quorum” or the “Corporation”) announces effective immediately, the appointment of Mr. William (“Bill”) Nurthen to Quorum’s Board of Directors.Mr. Nurthen will be joining existing Quorum Board members Maury Marks, Joe Campbell, Scot Eisenfelder, Jon Hook, D. Neil McDonnell and Greg Pollard.“I am delighted to be welcoming Bill to Quorum’s Board of Directors,” said Mr. Maury Marks, founder, President and CEO of Quorum. “Bill brings over two decades of leadership in key areas such as financial operations, investor relations and mergers and acquisitions. Bill’s experience will allow Quorum to further drive our organizational growth, industry stature and leadership, and financial success.”Mr. Nurthen brings...

Continue reading

In Honor of Men’s Health Month, Teleflex Announces Virtual Community Health Talk for Men with Benign Prostatic Hyperplasia

WAYNE, Pa., June 08, 2020 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) today announced that the company will host a free community health talk to discuss the symptoms, diagnosis and treatment options for enlarged prostate, also known as Benign Prostatic Hyperplasia (BPH). Dr. Wayne Kuang* will lead the webinar which can be viewed live on Wednesday, June 17 at 8:00 a.m. PDT and again at 4:30 p.m. PDT. Men and / or their partners from anywhere in the U.S. can attend the event.BPH is a non-cancerous enlargement of the prostate that occurs as men age. This common condition is marked by bothersome urinary symptoms that can cause loss of productivity, depression, interrupted sleep and decreased quality of life.1 If left untreated, the condition can worsen over time and cause permanent bladder damage.2“We are excited to offer our...

Continue reading

Aerpio Announces Change to Virtual Format for its 2020 Annual Meeting of Stockholders due to COVID-19

CINCINNATI, June 08, 2020 (GLOBE NEWSWIRE) — Aerpio Pharmaceuticals, Inc. (the “Company”) (Nasdaq: ARPO), today announced that, due to the public health and safety concerns related to the novel coronavirus (COVID-19) pandemic and recommendations and orders from federal and state authorities, the location of its 2020 annual meeting has been changed to a virtual-only format. There is no change to the items of business to be addressed at the meeting, which are described in the original proxy materials previously distributed on or about May 8, 2020.The virtual annual meeting will be held on Wednesday, June 24, 2020 at 10:30 a.m., Eastern Time (“ET”), the same date and time as originally scheduled and communicated. Online access to the virtual annual meeting will begin at 10:15 a.m. ET. The virtual annual meeting will be presented in...

Continue reading

WSFS Management to present at the Boenning & Scattergood Virtual Community Bank Conference on June 10, 2020

WILMINGTON, Del., June 08, 2020 (GLOBE NEWSWIRE) — WSFS Financial Corporation (Nasdaq: WSFS), the parent company of WSFS Bank, will participate in the Boenning & Scattergood Virtual Community Bank Conference on June 10, 2020. Rodger Levenson, WSFS’ Chairman, President and Chief Executive Officer, will present at 2:00 p.m. EDT. The presentation will be followed by a question and answer session with Mr. Levenson, Dominic C. Canuso, WSFS’ Executive Vice President and Chief Financial Officer, and WSFS Board Member Thère duPont.Presentation Materials: WSFS will present the 1Q 2020 Investor Presentation, which is available on the Investor Relations section of WSFS’ website.About WSFS Financial CorporationWSFS Financial Corporation is a multi-billion-dollar financial services company. Its primary subsidiary, WSFS Bank, is the oldest...

Continue reading

Shockwave Medical Announces That CMS Has Created New Codes for Intravascular Lithotripsy

SANTA CLARA, Calif., June 08, 2020 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that the Centers for Medicare & Medicaid Services (CMS) has issued new codes for IVL procedures performed in peripheral arteries in both the hospital outpatient and inpatient settings. The new Healthcare Common Procedure Coding System (HCPCS) outpatient and International Classification of Diseases, Tenth Revision, Procedure Coding System (ICD-10-PCS) inpatient codes will go into effect on July 1 and October 1, 2020, respectively.  Under these new codes, Medicare payment rates for IVL procedures performed in the hospital outpatient and inpatient settings, respectively, are consistent...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.